iMagemHTT-009
iMagemHTT-009- FIH Evaluation of Novel Mutant Huntingtin PET Radioligand [11C]CHDI-00491009
Early Phase 1 study testing a procedure in Huntington's disease.
RecruitingEARLY/PHASE1RadiationClinicalTrials.govTreatment trial
Recruiting in: Leuven, Belgium
Sponsor: CHDI Foundation, Inc.
Preparing a short plain-English summary.